Printer-friendlyClinical trials find immunotherapy avelumab plus best supportive care (BSC) significantly prolongs overall survival compared to BSC alone.
Nancy E. Davidson, MD
Division Head
Professor of Medicine
About us
The Division of Oncology's work bridges the worlds of basic science, clinical diagnosis, and the treatment of cancer. Our clinics cover each cancer type and have a strong focus in clinical trials of new diagnostic and therapeutic approaches. Our work is supported by a portfolio of peer-reviewed grants, industry sponsored projects, and research endowments.